Keyphrases
Kidney
100%
Acute Kidney Injury
92%
Mesenchymal Stromal Cells
91%
Renal Artery Stenosis
63%
Membranous Nephropathy
59%
Adipokinetic Hormone
48%
Glomerulonephritis
48%
Human Kidney
45%
Monoclonal Gammopathy
45%
American Society
45%
Successful Treatment
45%
Onconephrology
45%
Stenotic Lesion
34%
Monoclonal Gammopathy of Renal Significance
33%
Kidney Biopsy
33%
Thrombotic Microangiopathy
31%
COVID-19
31%
Kidney Transplant Recipients
31%
Peritubular Capillary
29%
Phospholipase A2 Receptor (PLA2R)
29%
Chronic Kidney Disease
28%
Glomerular Disease
28%
Vascular Remodeling
26%
Newly Diagnosed
26%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
25%
Graft Outcome
25%
Rituximab
25%
Obesity
25%
Human Obesity
24%
Subfamily B
22%
Meta-analysis
22%
Fibrillary
22%
Living Donor Kidney Transplantation
22%
Atherosclerotic Renal Artery Stenosis
22%
COVID-19 Vaccination
22%
DnaJ
22%
Donor-recipient Matching
22%
Obese Patients
22%
Angiogenic Signaling
22%
Shock Wave Therapy
22%
Obinutuzumab
22%
Low Intensity
22%
Mycobacterium Septicum
22%
Caffeine Intake
22%
Bamlanivimab
22%
Shock
22%
Fibrillary Glomerulonephritis
22%
Chronic Hepatitis C
22%
Shock Waves
22%
Kidney Regeneration
22%
Medicine and Dentistry
Adipose Tissue
91%
Stromal Cell
91%
Acute Kidney Injury
91%
Glomerulonephritis
73%
Kidney Graft
56%
Monoclonal Gammopathy of Undetermined Significance
51%
Nephrology
45%
Nephropathy
45%
Renal Artery Stenosis
44%
Chronic Kidney Disease
40%
Creatinine
35%
COVID-19
34%
Glomerulopathy
33%
Stem Cell
32%
Kidney Injury
31%
Allograft
30%
Thrombotic Thrombocytopenic Purpura
30%
Renal Biopsy
29%
Capillary
28%
Systematic Review
27%
Living Donors
26%
Light Chain
26%
Kidney Allograft
25%
Mesenchymal Stem Cell
22%
Human Embryonic Stem Cell
22%
Resistant Hypertension
22%
Prostate Cancer
22%
Chronic Hepatitis C
22%
Chronic Graft Versus Host Disease
22%
Meta-Analysis
22%
Heart Protection
22%
Peritonitis
22%
Complement Component C4d
22%
COVID-19 Vaccination
22%
Fibril
22%
Extracorporeal Shockwave Therapy
22%
Nonsteroid Antiinflammatory Agent
22%
Mycobacteria
22%
Renal Failure
22%
Graft Survival
22%
Renin
22%
Aldosterone
22%
Graft Versus Host Reaction
22%
Nephron
22%
Hematopoietic Cell
22%
Non-Relapse Mortality
22%
Comorbidity
22%
Intracavitary Brachytherapy
22%
Interstitial Brachytherapy
22%
Cervical Cancer
22%